Feasibility and acceptability of an intranasal diamorphine spray as an alternative to injectable diamorphine for maintenance treatment

European Addiction Research

Volumn 12, Issue 2, 2006, Pages 91-95

  Mitchell, Timothy B ^a   Lintzeris, Nicholas ^a   Bond, Alyson ^a   Strang, John ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Diamorphine, intranasal; Heroin; Maintenance treatment

Indexed keywords

DIAMORPHINE; METHADONE; MORPHINE; MORPHINE 6 ACETATE;

ADULT; ARTICLE; CASE REPORT; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; FEASIBILITY STUDY; FEMALE; HAZARD ASSESSMENT; HUMAN; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; PRURITUS; VELOCITY;

ADMINISTRATION, INTRANASAL; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; FEMALE; FOLLOW-UP STUDIES; HEROIN; HEROIN DEPENDENCE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MORPHINE DERIVATIVES; NARCOTICS; SUBSTANCE ABUSE DETECTION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 33645000867     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090428     Document Type: Article

References (12)

1. Perneger TV, Giner F, Del Rio M, Mino A: Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ 1998;317:13-18.
2. Van Den Brink W, Hendriks VM, Blanken P, Koeter MW, Van Zwieten BJ, Van Ree JM: Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ 2003;327:310.
3. Rosenberg H, Melville J, Mclean PC: Acceptability and availability of pharmacological interventions for substance misuse by British NHS treatment services. Addiction 2002;97:59-65.
4. Sell L, Farrell M, Robson P: Prescription of diamorphine, dipipanone, and cocaine in England and Wales. Drug Alcohol Rev 1997;16:221-226.
5. Gossop M, Stewart D, Marsden J, Kidd T, Strang J: Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment. Addict Behav 2004;29:1085-1094.
6. Strang J, Sheridan J: Heroin prescribing in the 'British System' of the mid 1990s: data from the 1995 national survey of community pharmacies in England and Wales. Drug Alcohol Rev 1997;16:7-16.
7. Skopp G, Ganssmann B, Cone EJ, Aderjan R: Plasma concentrations of heroin and morphine-related metabolites after intranasal and intramuscular administration. J Anal Toxicol 1997;21:105-111.
8. Cone EJ, Holicky BA, Grant TM, Darwin WD, Goldberger BA: Pharmacokinetics and pharmacodynamics of intranasal 'snorted' heroin. J Anal Toxicol 1993;17:327-337.
9. Kendall JM, Latter VS: Intranasal diamorphine as an alternative to intramuscular morphine: pharmacokinetic and pharmacodynamic aspects. Clin Pharmacokinet 2003;42:501-513.
10. Comer SD, Collins ED, Fischman MW: Choice between money and intranasal heroin in morphine-maintained humans. Behav Pharmacol 1997;8:677-690.
11. Comer SD, Collins ED, Macarthur RB, Fischman MW: Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans. Psychopharmacology 1999;143:327-338.
12. Handelsman L, Cochrane KJ, Aronson MJ, Ness R, Rubinstein KJ, Kanof PD: Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 1987;13:293-308.